Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
ACTIVE NOT RECRUITING
NCT06710470

A Study on the Safety of Deucravacitinib Exposure in Pregnant Women and Their Offspring

Sponsor: Bristol-Myers Squibb

View on ClinicalTrials.gov

Summary

This observational study aims to assess pregnancy and infant outcomes among pregnant women with psoriasis who have been exposed to deucravacitinib treatment in the USA.

Official title: Deucravacitinib Pregnancy Study: A Retrospective Observational Study on the Safety of Deucravacitinib Exposure in Pregnant Women and Their Offspring

Key Details

Gender

FEMALE

Age Range

15 Years - 50 Years

Study Type

OBSERVATIONAL

Enrollment

833

Start Date

2024-08-02

Completion Date

2029-02-28

Last Updated

2024-11-29

Healthy Volunteers

No

Conditions

Interventions

DRUG

Deucravacitinib

As per product label

DRUG

Systemic psoriasis medications

As per product label

OTHER

No systemic medications

Participants not exposed to any systemic medications

Locations (1)

Bristol-Meyers Squibb

Lawrenceville, New Jersey, United States